logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
Endocrinology and Metabolism Clinics of North America cover

Endocrinology and Metabolism Clinics of North America

IF4.2
Papers102
Citations4665
Journal Papers 100
Publication Date
delete
Adjunctive Therapies in Type 1 Diabetes
deleteEndocrinology and Metabolism Clinics of North America
IF4.2
delete2026-07-29
delete0
PREAI
deleteCourtney A. Ackeifi; Viral N. Shah
deleteShare
deleteSave
Sodium-Glucose Cotransporter-Inhibitors, Incretin Receptor Agonists (Glucagon-Like Peptide-1 Receptor Agonists and Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists), and Finerenone for Kidney Protection in Type 1 Diabetes
deleteEndocrinology and Metabolism Clinics of North America
IF4.2
delete2026-06-11
delete0
PREAI
deleteMichael S. Hughes; Francisco J. Pasquel
deleteShare
deleteSave
Beyond Glycemia in T1D-Part 2
deleteEndocrinology and Metabolism Clinics of North America
IF4.2
delete2026-06-01
delete0
PREAI
deleteJairo A. Pinzon Cortes; Phoom Narongkiatikhun; Coco Fuhri Snethlage; Darwin Del Castillo; Kalie L. Tommerdahl; Kristen J. Nadeau; Petter Bjornstad
deleteShare
deleteSave
Combination of Glucagon-like Peptide-1 Receptor Agonists and Sodium–Glucose Cotransporter Inhibitors in Type 1 Diabetes: Why, when and How? An Exploration of the Rationale and Clinical Scenarios for Combining These 2 Adjunctive Agents
deleteEndocrinology and Metabolism Clinics of North America
IF4.2
delete2026-05-28
delete0
PREAI
deleteHusam Ghanim; Sambasiva Rao Srungavarapu; Paresh Dandona; Ajay Chaudhuri
deleteShare
deleteSave
Beyond Glycemia in T1D
deleteEndocrinology and Metabolism Clinics of North America
IF4.2
delete2026-05-27
delete0
PREAI
deleteJairo A. Pinzon Cortes; Phoom Narongkiatikhun; Coco M. Fuhri Snethlage; Darwin Del Castillo; Kalie L. Tommerdahl; Kristen J. Nadeau; Petter Bjornstad
deleteShare
deleteSave
Type 1 Diabetes Management Beyond Insulin: Aligning Evidence, Research, and Regulation
deleteEndocrinology and Metabolism Clinics of North America
IF4.2
delete2026-05-26
delete0
PREAI
deleteCourtney A. Ackeifi; Viral N. Shah
deleteShare
deleteSave
Update in Adrenal Steroidogenesis and Congenital Adrenal Hyperplasia
deleteEndocrinology and Metabolism Clinics of North America
IF4.2
delete2026-05-23
delete0
PREAI
deleteBouliari, Athanasia; Lekarev, Oksana; Lin-Su, Karen
deleteShare
deleteSave
Emerging Evidence for Cardiorenal Protection with Sodium–Glucose Cotransporter Inhibitors, Glucagon-like peptide-1 Receptor Agonists, and Mineralocorticoid Receptor Blockers in People with Type 1 Diabetes
deleteEndocrinology and Metabolism Clinics of North America
IF4.2
delete2026-05-22
delete0
PREAI
deleteStuti Fernades; Barbara Hettinger; Lynn Ang; Rodica Pop-Busui
deleteShare
deleteSave
The Horizon Ahead
deleteEndocrinology and Metabolism Clinics of North America
IF4.2
delete2026-05-22
delete0
PREAI
deleteVala Hamidi; Jeremy H. Pettus
deleteShare
deleteSave
Expectations and Experiences
deleteEndocrinology and Metabolism Clinics of North America
IF4.2
delete2026-05-20
delete0
PREAI
deleteJulie Keller Heverly
deleteShare
deleteSave
Clinical Guidance on the Safe Use of Glucagon-like Peptide-1 Receptor Agonists in Adults with Type 1 Diabetes
deleteEndocrinology and Metabolism Clinics of North America
IF4.2
delete2026-05-19
delete0
PREAI
deleteZeb I. Saeed; Viral N. Shah
deleteShare
deleteSave
Daily Glucagon-like Peptide-1 Receptor Agonists in Type 1 Diabetes
deleteEndocrinology and Metabolism Clinics of North America
IF4.2
delete2026-05-18
delete0
PREAI
deleteRachael Innes; John R. Petrie; Thomas Fremming Dejgaard
deleteShare
deleteSave
Future of Continuous Ketone Monitoring and Its Utility for Safe Use of Sodium-glucose Cotransporter-2 Inhibitors in Type 1 Diabetes
deleteEndocrinology and Metabolism Clinics of North America
IF4.2
delete2026-05-18
delete0
PREAI
deleteHalis K. Akturk
deleteShare
deleteSave
GLP-1 Receptor Agonists May Reduce Insulin Requirements in New-Onset Type 1 Diabetes
deleteEndocrinology and Metabolism Clinics of North America
IF4.2
delete2026-05-18
delete0
PREAI
deleteJustin M. Gregory
deleteShare
deleteSave
Weekly Glucagon-Like Peptide-1 Receptor Agonists in Type 1 diabetes
deleteEndocrinology and Metabolism Clinics of North America
IF4.2
delete2026-05-15
delete0
PREAI
deleteAmy Stein; Meghan Pauley; Janet Snell-Bergeon
deleteShare
deleteSave
Current State of Cardiorenal Disease in People with Type 1 Diabetes
deleteEndocrinology and Metabolism Clinics of North America
IF4.2
delete2026-05-14
delete0
PREAI
deleteStuti Fernades; Barbara Hettinger; Lynn Ang; Rodica Pop-Busui
deleteShare
deleteSave
Beyond Insulin
deleteEndocrinology and Metabolism Clinics of North America
IF4.2
delete2026-05-14
delete0
PREAI
deleteHuajing Ni; Jennifer R. Snaith; Jerry R. Greenfield
deleteShare
deleteSave
Updates in Adrenal Disorders
deleteEndocrinology and Metabolism Clinics of North America
IF4.2
delete2026-04-29
delete0
PREAI
deleteSmita B. Abraham
deleteShare
deleteSave
Adrenal Incidentalomas
deleteEndocrinology and Metabolism Clinics of North America
IF4.2
delete2026-03-14
delete0
PREAI
deleteNoah A. Bloomgarden; Robert Berkenblit
deleteShare
deleteSave
Pheochromocytomas and paragangliomas
delete
IF4.2
delete2026-03-13
delete0
PREAI
deleteHussam Alkaissi; David Taieb; Hans K. Ghayee
deleteShare
deleteSave